. To conduct a targeted literature review to examine the impact of cognitive impairment and negative symptoms among patients with schizophrenia treated in the United States across a range of outcomes pertinent to the US health care system decision-makers, such as payers and policy-makers. The authors searched EMBASE and PubMed from January 2012 to January 2024.
View Article and Find Full Text PDF